Milgamma (Benfotiamine_pyridoxine hydrochloride) Uses, Dosage, Side Effects and more
Benfotiamine has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.
| Attribute | Details |
|---|---|
| Trade Name | Milgamma (Benfotiamine_pyridoxine hydrochloride) |
| Generic | Benfotiamine + Pyridoxine Hydrochloride |
| Type | |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Argentina, Bosnia & Herzegowina, Bulgaria, Estonia, Georgia, Germany, Hong Kong, Hungary, Latvia, Lithuania, Poland, Romania, Serbia, Slovenia |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Benfotiamine is a derivative of thiamine thought to be useful in the management of diabetic neuropathy, although evidence is lacking.
Milgamma (Benfotiamine_pyridoxine hydrochloride) is also used to associated treatment for these conditions: Thiamine Deficiency
